Are Smart Investors Making the Right Decision? Aptose Biosciences Inc (APTO)

With 3.39 million shares changed hands, the volume of the stock remained lighter than its average volume of 12.51 million shares. The 52-week range on APTO shows that it touched its highest point at $1.94 and its lowest point at $0.13 during that stretch. It currently has a 1-year price target of $2.00. Beta for the stock currently stands at 1.09.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APTO was down-trending over the past week, with a drop of -42.98%, but this was down by -48.17% over a month. Three-month performance dropped to -59.58% while six-month performance fell -72.67%. The stock lost -93.80% in the past year, while it has lost -51.00% so far this year.

Float and Shares Shorts:

At present, 60.18 million APTO shares are outstanding with a float of 56.51 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for APTO since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.79 being high and -$1.79 being low. For APTO, this leads to a yearly average estimate of -$1.79. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.